Sartorius Stedim Biotech S.A.
SRTOY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $23 | $27 | $35 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $3 | $4 | $1 | $1 |
| Enterprise Value | $21 | $26 | $28 | $36 |
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Gross Profit | $1 | $1 | $2 | $2 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 24.1% | 27.2% | 38.1% | 28.1% |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS Diluted | 0.18 | 0.34 | 0.95 | 0.45 |
| % Growth | -47.1% | -64.2% | 111.1% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |